Cervical and anal HPV infection: cytological and histological abnormalities in HIV-infected women in Thailand. 2015

Reshmie A Ramautarsing, and Nittaya Phanuphak, and Surasith Chaithongwongwatthana, and Ferdinand Wnm Wit, and Nipat Teeratakulpisarn, and Tippawan Pankam, and Piyanee Rodbamrung, and Janneke H Wijgert, and Joep Ma Lange, and Praphan Phanuphak, and Vikrant V Sahasrabuddhe, and Stephen Kerr, and Jintanat Ananworanich
HIV Netherlands Australia Thailand Research Collaboration (HIVNAT), Bangkok, Thailand; Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam, the Netherlands.

BACKGROUND Women infected with human immunodeficiency virus (HIV) have higher rates of persistent infection with high-risk human papillomavirus (hr-HPV) and cervical and anal dysplasia. We describe the epidemiology of hr-HPV, and cervical and anal intra-epithelial abnormalities in HIV-infected women in Thailand. METHODS HIV-infected women aged 18-49 years, either HAART-naïve or -experienced, were enrolled in Bangkok, Thailand. A demographic and sexual-risk behaviour questionnaire was administered and a pelvic examination with colposcopy was performed on every woman. Cervical and anal samples were tested for cytology and HPV genotyping. RESULTS A total of 256 women were enrolled with a median [interquartile range (IQR)] age of 35 (32-40) years. Ninety (35.2%) had detectable cervical hr-HPV. Being post-menopausal was associated with increased risk for cervical hr-HPV, while years since HIV diagnosis and plasma HIV RNA <40 copies/mL were significantly associated with decreased risk in multivariable regression analyses. Abnormal cervical cytology was detected in 6.3%. Cervical biopsies that were taken from 99 women (39.3%) owing to abnormalities seen during colposcopy showed cervical intra-epithelial neoplasia (CIN) in 22.6%. The sensitivity of cervical cytology to detect CIN2+ was 10.0%. Among 102 women enrolled in the anal substudy, 18.8% had anal HPV infection and 11.1% had anal hr-HPV. Two women had abnormal anal cytology. CONCLUSIONS We found cervical and anal hr-HPV in 35.2% and 11.1% of Thai HIV-infected women, respectively. Moreover, the observed poor agreement between cervical cytology and histology results could indicate current cervical cancer screening programs for HIV-infected women might not be optimal for the detection of pre-neoplastic lesions.

UI MeSH Term Description Entries

Related Publications

Reshmie A Ramautarsing, and Nittaya Phanuphak, and Surasith Chaithongwongwatthana, and Ferdinand Wnm Wit, and Nipat Teeratakulpisarn, and Tippawan Pankam, and Piyanee Rodbamrung, and Janneke H Wijgert, and Joep Ma Lange, and Praphan Phanuphak, and Vikrant V Sahasrabuddhe, and Stephen Kerr, and Jintanat Ananworanich
January 1998, International journal of STD & AIDS,
Reshmie A Ramautarsing, and Nittaya Phanuphak, and Surasith Chaithongwongwatthana, and Ferdinand Wnm Wit, and Nipat Teeratakulpisarn, and Tippawan Pankam, and Piyanee Rodbamrung, and Janneke H Wijgert, and Joep Ma Lange, and Praphan Phanuphak, and Vikrant V Sahasrabuddhe, and Stephen Kerr, and Jintanat Ananworanich
June 2016, HIV medicine,
Reshmie A Ramautarsing, and Nittaya Phanuphak, and Surasith Chaithongwongwatthana, and Ferdinand Wnm Wit, and Nipat Teeratakulpisarn, and Tippawan Pankam, and Piyanee Rodbamrung, and Janneke H Wijgert, and Joep Ma Lange, and Praphan Phanuphak, and Vikrant V Sahasrabuddhe, and Stephen Kerr, and Jintanat Ananworanich
December 2016, The journal of obstetrics and gynaecology research,
Reshmie A Ramautarsing, and Nittaya Phanuphak, and Surasith Chaithongwongwatthana, and Ferdinand Wnm Wit, and Nipat Teeratakulpisarn, and Tippawan Pankam, and Piyanee Rodbamrung, and Janneke H Wijgert, and Joep Ma Lange, and Praphan Phanuphak, and Vikrant V Sahasrabuddhe, and Stephen Kerr, and Jintanat Ananworanich
June 1997, Genitourinary medicine,
Reshmie A Ramautarsing, and Nittaya Phanuphak, and Surasith Chaithongwongwatthana, and Ferdinand Wnm Wit, and Nipat Teeratakulpisarn, and Tippawan Pankam, and Piyanee Rodbamrung, and Janneke H Wijgert, and Joep Ma Lange, and Praphan Phanuphak, and Vikrant V Sahasrabuddhe, and Stephen Kerr, and Jintanat Ananworanich
January 2015, The Journal of infection,
Reshmie A Ramautarsing, and Nittaya Phanuphak, and Surasith Chaithongwongwatthana, and Ferdinand Wnm Wit, and Nipat Teeratakulpisarn, and Tippawan Pankam, and Piyanee Rodbamrung, and Janneke H Wijgert, and Joep Ma Lange, and Praphan Phanuphak, and Vikrant V Sahasrabuddhe, and Stephen Kerr, and Jintanat Ananworanich
October 2012, HIV medicine,
Reshmie A Ramautarsing, and Nittaya Phanuphak, and Surasith Chaithongwongwatthana, and Ferdinand Wnm Wit, and Nipat Teeratakulpisarn, and Tippawan Pankam, and Piyanee Rodbamrung, and Janneke H Wijgert, and Joep Ma Lange, and Praphan Phanuphak, and Vikrant V Sahasrabuddhe, and Stephen Kerr, and Jintanat Ananworanich
January 2013, International journal of women's health,
Reshmie A Ramautarsing, and Nittaya Phanuphak, and Surasith Chaithongwongwatthana, and Ferdinand Wnm Wit, and Nipat Teeratakulpisarn, and Tippawan Pankam, and Piyanee Rodbamrung, and Janneke H Wijgert, and Joep Ma Lange, and Praphan Phanuphak, and Vikrant V Sahasrabuddhe, and Stephen Kerr, and Jintanat Ananworanich
July 2013, The Journal of infectious diseases,
Reshmie A Ramautarsing, and Nittaya Phanuphak, and Surasith Chaithongwongwatthana, and Ferdinand Wnm Wit, and Nipat Teeratakulpisarn, and Tippawan Pankam, and Piyanee Rodbamrung, and Janneke H Wijgert, and Joep Ma Lange, and Praphan Phanuphak, and Vikrant V Sahasrabuddhe, and Stephen Kerr, and Jintanat Ananworanich
May 2011, Diagnostic cytopathology,
Reshmie A Ramautarsing, and Nittaya Phanuphak, and Surasith Chaithongwongwatthana, and Ferdinand Wnm Wit, and Nipat Teeratakulpisarn, and Tippawan Pankam, and Piyanee Rodbamrung, and Janneke H Wijgert, and Joep Ma Lange, and Praphan Phanuphak, and Vikrant V Sahasrabuddhe, and Stephen Kerr, and Jintanat Ananworanich
November 2014, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Copied contents to your clipboard!